nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—NISCH—Podofilox—Teniposide—lung cancer	0.0047	0.239	CbGdCrCtD
Guanabenz—NISCH—Paclitaxel—Docetaxel—lung cancer	0.00435	0.222	CbGdCrCtD
Guanabenz—NISCH—mammary gland—lung cancer	0.00418	0.194	CbGeAlD
Guanabenz—NISCH—Vincristine—Vinorelbine—lung cancer	0.00299	0.152	CbGdCrCtD
Guanabenz—NISCH—Podofilox—Etoposide—lung cancer	0.0028	0.142	CbGdCrCtD
Guanabenz—NISCH—Vinblastine—Vinorelbine—lung cancer	0.00241	0.123	CbGdCrCtD
Guanabenz—NISCH—Vincristine—Vinblastine—lung cancer	0.00239	0.122	CbGdCrCtD
Guanabenz—NISCH—bronchus—lung cancer	0.00229	0.106	CbGeAlD
Guanabenz—NISCH—trachea—lung cancer	0.00206	0.0955	CbGeAlD
Guanabenz—NISCH—bone marrow—lung cancer	0.00163	0.0757	CbGeAlD
Guanabenz—NISCH—lung—lung cancer	0.00148	0.0686	CbGeAlD
Guanabenz—CYP1A2—respiratory system—lung cancer	0.0011	0.0512	CbGeAlD
Guanabenz—ADRA2C—bronchus—lung cancer	0.00105	0.0486	CbGeAlD
Guanabenz—NISCH—lymph node—lung cancer	0.00101	0.0469	CbGeAlD
Guanabenz—ADRA2C—trachea—lung cancer	0.00094	0.0436	CbGeAlD
Guanabenz—ADRA2C—cardiac atrium—lung cancer	0.000883	0.041	CbGeAlD
Guanabenz—ADRA2A—bronchus—lung cancer	0.000835	0.0388	CbGeAlD
Guanabenz—ADRA2A—trachea—lung cancer	0.00075	0.0348	CbGeAlD
Guanabenz—ADRA2A—cardiac atrium—lung cancer	0.000705	0.0327	CbGeAlD
Guanabenz—ADRA2C—lung—lung cancer	0.000676	0.0313	CbGeAlD
Guanabenz—CYP1A2—lung—lung cancer	0.000586	0.0272	CbGeAlD
Guanabenz—ADRA2A—lung—lung cancer	0.000539	0.025	CbGeAlD
Guanabenz—ADRA2C—lymph node—lung cancer	0.000462	0.0214	CbGeAlD
Guanabenz—ADRA2A—lymph node—lung cancer	0.000369	0.0171	CbGeAlD
Guanabenz—Hypotension—Etoposide—lung cancer	0.00033	0.000411	CcSEcCtD
Guanabenz—Gastritis—Doxorubicin—lung cancer	0.00033	0.000411	CcSEcCtD
Guanabenz—Pain—Cisplatin—lung cancer	0.00033	0.00041	CcSEcCtD
Guanabenz—Vomiting—Vinorelbine—lung cancer	0.000328	0.000408	CcSEcCtD
Guanabenz—Body temperature increased—Gemcitabine—lung cancer	0.000327	0.000407	CcSEcCtD
Guanabenz—Rash—Vinorelbine—lung cancer	0.000325	0.000404	CcSEcCtD
Guanabenz—Dermatitis—Vinorelbine—lung cancer	0.000325	0.000404	CcSEcCtD
Guanabenz—Abdominal distension—Doxorubicin—lung cancer	0.000325	0.000404	CcSEcCtD
Guanabenz—Hypotension—Paclitaxel—lung cancer	0.000324	0.000403	CcSEcCtD
Guanabenz—Headache—Vinorelbine—lung cancer	0.000323	0.000402	CcSEcCtD
Guanabenz—Syncope—Docetaxel—lung cancer	0.000323	0.000402	CcSEcCtD
Guanabenz—Influenza—Doxorubicin—lung cancer	0.000323	0.000401	CcSEcCtD
Guanabenz—Leukopenia—Docetaxel—lung cancer	0.000322	0.000401	CcSEcCtD
Guanabenz—Feeling abnormal—Cisplatin—lung cancer	0.000318	0.000396	CcSEcCtD
Guanabenz—Paraesthesia—Etoposide—lung cancer	0.000318	0.000395	CcSEcCtD
Guanabenz—Loss of consciousness—Docetaxel—lung cancer	0.000316	0.000394	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000316	0.000393	CcSEcCtD
Guanabenz—Dyspnoea—Etoposide—lung cancer	0.000315	0.000392	CcSEcCtD
Guanabenz—Cough—Docetaxel—lung cancer	0.000314	0.000391	CcSEcCtD
Guanabenz—Hypersensitivity—Irinotecan—lung cancer	0.000313	0.000389	CcSEcCtD
Guanabenz—Paraesthesia—Paclitaxel—lung cancer	0.000311	0.000387	CcSEcCtD
Guanabenz—Hypertension—Docetaxel—lung cancer	0.000311	0.000387	CcSEcCtD
Guanabenz—Dyspnoea—Paclitaxel—lung cancer	0.000309	0.000384	CcSEcCtD
Guanabenz—Decreased appetite—Etoposide—lung cancer	0.000307	0.000382	CcSEcCtD
Guanabenz—Chest pain—Docetaxel—lung cancer	0.000307	0.000381	CcSEcCtD
Guanabenz—Myalgia—Docetaxel—lung cancer	0.000307	0.000381	CcSEcCtD
Guanabenz—Arthralgia—Docetaxel—lung cancer	0.000307	0.000381	CcSEcCtD
Guanabenz—Nausea—Vinorelbine—lung cancer	0.000306	0.000381	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Etoposide—lung cancer	0.000305	0.00038	CcSEcCtD
Guanabenz—Dyspepsia—Paclitaxel—lung cancer	0.000305	0.00038	CcSEcCtD
Guanabenz—Body temperature increased—Cisplatin—lung cancer	0.000305	0.000379	CcSEcCtD
Guanabenz—Asthenia—Irinotecan—lung cancer	0.000305	0.000379	CcSEcCtD
Guanabenz—Fatigue—Etoposide—lung cancer	0.000305	0.000379	CcSEcCtD
Guanabenz—Pain—Etoposide—lung cancer	0.000302	0.000376	CcSEcCtD
Guanabenz—Constipation—Etoposide—lung cancer	0.000302	0.000376	CcSEcCtD
Guanabenz—Decreased appetite—Paclitaxel—lung cancer	0.000301	0.000375	CcSEcCtD
Guanabenz—Dry mouth—Docetaxel—lung cancer	0.0003	0.000373	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Doxorubicin—lung cancer	0.0003	0.000373	CcSEcCtD
Guanabenz—Haemoglobin—Methotrexate—lung cancer	0.0003	0.000373	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000299	0.000372	CcSEcCtD
Guanabenz—Fatigue—Paclitaxel—lung cancer	0.000299	0.000372	CcSEcCtD
Guanabenz—Haemorrhage—Methotrexate—lung cancer	0.000298	0.000371	CcSEcCtD
Guanabenz—Asthenia—Gemcitabine—lung cancer	0.000297	0.000369	CcSEcCtD
Guanabenz—Pain—Paclitaxel—lung cancer	0.000296	0.000369	CcSEcCtD
Guanabenz—Constipation—Paclitaxel—lung cancer	0.000296	0.000369	CcSEcCtD
Guanabenz—Confusional state—Docetaxel—lung cancer	0.000296	0.000368	CcSEcCtD
Guanabenz—Oedema—Docetaxel—lung cancer	0.000294	0.000365	CcSEcCtD
Guanabenz—Weight increased—Doxorubicin—lung cancer	0.000294	0.000365	CcSEcCtD
Guanabenz—Pruritus—Gemcitabine—lung cancer	0.000293	0.000364	CcSEcCtD
Guanabenz—Infection—Docetaxel—lung cancer	0.000292	0.000363	CcSEcCtD
Guanabenz—Weight decreased—Doxorubicin—lung cancer	0.000292	0.000363	CcSEcCtD
Guanabenz—Feeling abnormal—Etoposide—lung cancer	0.000291	0.000362	CcSEcCtD
Guanabenz—Hyperglycaemia—Doxorubicin—lung cancer	0.000291	0.000362	CcSEcCtD
Guanabenz—Diarrhoea—Irinotecan—lung cancer	0.000291	0.000362	CcSEcCtD
Guanabenz—Gastrointestinal pain—Etoposide—lung cancer	0.000289	0.00036	CcSEcCtD
Guanabenz—Shock—Docetaxel—lung cancer	0.000289	0.00036	CcSEcCtD
Guanabenz—Nervous system disorder—Docetaxel—lung cancer	0.000288	0.000358	CcSEcCtD
Guanabenz—Thrombocytopenia—Docetaxel—lung cancer	0.000288	0.000358	CcSEcCtD
Guanabenz—Infestation NOS—Doxorubicin—lung cancer	0.000288	0.000358	CcSEcCtD
Guanabenz—Infestation—Doxorubicin—lung cancer	0.000288	0.000358	CcSEcCtD
Guanabenz—Tachycardia—Docetaxel—lung cancer	0.000287	0.000357	CcSEcCtD
Guanabenz—Feeling abnormal—Paclitaxel—lung cancer	0.000286	0.000355	CcSEcCtD
Guanabenz—Skin disorder—Docetaxel—lung cancer	0.000285	0.000355	CcSEcCtD
Guanabenz—Hypersensitivity—Cisplatin—lung cancer	0.000284	0.000354	CcSEcCtD
Guanabenz—Gastrointestinal pain—Paclitaxel—lung cancer	0.000284	0.000353	CcSEcCtD
Guanabenz—Diarrhoea—Gemcitabine—lung cancer	0.000283	0.000352	CcSEcCtD
Guanabenz—Erythema multiforme—Methotrexate—lung cancer	0.000282	0.000351	CcSEcCtD
Guanabenz—Dizziness—Irinotecan—lung cancer	0.000281	0.00035	CcSEcCtD
Guanabenz—Urticaria—Etoposide—lung cancer	0.000281	0.000349	CcSEcCtD
Guanabenz—Anorexia—Docetaxel—lung cancer	0.00028	0.000348	CcSEcCtD
Guanabenz—Abdominal pain—Etoposide—lung cancer	0.00028	0.000348	CcSEcCtD
Guanabenz—Body temperature increased—Etoposide—lung cancer	0.00028	0.000348	CcSEcCtD
Guanabenz—Eye disorder—Methotrexate—lung cancer	0.000279	0.000346	CcSEcCtD
Guanabenz—Tinnitus—Methotrexate—lung cancer	0.000278	0.000346	CcSEcCtD
Guanabenz—Asthenia—Cisplatin—lung cancer	0.000277	0.000344	CcSEcCtD
Guanabenz—Urticaria—Paclitaxel—lung cancer	0.000275	0.000342	CcSEcCtD
Guanabenz—Hypotension—Docetaxel—lung cancer	0.000275	0.000341	CcSEcCtD
Guanabenz—Abdominal pain—Paclitaxel—lung cancer	0.000274	0.000341	CcSEcCtD
Guanabenz—Body temperature increased—Paclitaxel—lung cancer	0.000274	0.000341	CcSEcCtD
Guanabenz—Vomiting—Irinotecan—lung cancer	0.00027	0.000336	CcSEcCtD
Guanabenz—Immune system disorder—Methotrexate—lung cancer	0.000269	0.000335	CcSEcCtD
Guanabenz—Mediastinal disorder—Methotrexate—lung cancer	0.000269	0.000334	CcSEcCtD
Guanabenz—Rash—Irinotecan—lung cancer	0.000268	0.000333	CcSEcCtD
Guanabenz—Dermatitis—Irinotecan—lung cancer	0.000268	0.000333	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000268	0.000333	CcSEcCtD
Guanabenz—Chills—Methotrexate—lung cancer	0.000267	0.000333	CcSEcCtD
Guanabenz—Headache—Irinotecan—lung cancer	0.000266	0.000331	CcSEcCtD
Guanabenz—Diarrhoea—Cisplatin—lung cancer	0.000264	0.000328	CcSEcCtD
Guanabenz—Paraesthesia—Docetaxel—lung cancer	0.000264	0.000328	CcSEcCtD
Guanabenz—Vomiting—Gemcitabine—lung cancer	0.000263	0.000327	CcSEcCtD
Guanabenz—Dyspnoea—Docetaxel—lung cancer	0.000262	0.000326	CcSEcCtD
Guanabenz—Rash—Gemcitabine—lung cancer	0.000261	0.000325	CcSEcCtD
Guanabenz—Dermatitis—Gemcitabine—lung cancer	0.000261	0.000324	CcSEcCtD
Guanabenz—Hypersensitivity—Etoposide—lung cancer	0.000261	0.000324	CcSEcCtD
Guanabenz—Malnutrition—Methotrexate—lung cancer	0.00026	0.000323	CcSEcCtD
Guanabenz—Erythema—Methotrexate—lung cancer	0.00026	0.000323	CcSEcCtD
Guanabenz—Haemoglobin—Doxorubicin—lung cancer	0.000259	0.000323	CcSEcCtD
Guanabenz—Headache—Gemcitabine—lung cancer	0.000259	0.000323	CcSEcCtD
Guanabenz—Dyspepsia—Docetaxel—lung cancer	0.000259	0.000322	CcSEcCtD
Guanabenz—Haemorrhage—Doxorubicin—lung cancer	0.000258	0.000321	CcSEcCtD
Guanabenz—Decreased appetite—Docetaxel—lung cancer	0.000255	0.000318	CcSEcCtD
Guanabenz—Hypersensitivity—Paclitaxel—lung cancer	0.000255	0.000318	CcSEcCtD
Guanabenz—Oedema peripheral—Doxorubicin—lung cancer	0.000254	0.000316	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Docetaxel—lung cancer	0.000254	0.000315	CcSEcCtD
Guanabenz—Asthenia—Etoposide—lung cancer	0.000254	0.000315	CcSEcCtD
Guanabenz—Connective tissue disorder—Doxorubicin—lung cancer	0.000254	0.000315	CcSEcCtD
Guanabenz—Fatigue—Docetaxel—lung cancer	0.000253	0.000315	CcSEcCtD
Guanabenz—Nausea—Irinotecan—lung cancer	0.000253	0.000314	CcSEcCtD
Guanabenz—Pain—Docetaxel—lung cancer	0.000251	0.000312	CcSEcCtD
Guanabenz—Constipation—Docetaxel—lung cancer	0.000251	0.000312	CcSEcCtD
Guanabenz—Back pain—Methotrexate—lung cancer	0.000251	0.000312	CcSEcCtD
Guanabenz—Pruritus—Etoposide—lung cancer	0.00025	0.000311	CcSEcCtD
Guanabenz—Asthenia—Paclitaxel—lung cancer	0.000249	0.000309	CcSEcCtD
Guanabenz—Nausea—Gemcitabine—lung cancer	0.000246	0.000306	CcSEcCtD
Guanabenz—Vomiting—Cisplatin—lung cancer	0.000245	0.000305	CcSEcCtD
Guanabenz—Pruritus—Paclitaxel—lung cancer	0.000245	0.000305	CcSEcCtD
Guanabenz—Vision blurred—Methotrexate—lung cancer	0.000245	0.000304	CcSEcCtD
Guanabenz—Erythema multiforme—Doxorubicin—lung cancer	0.000244	0.000304	CcSEcCtD
Guanabenz—Rash—Cisplatin—lung cancer	0.000243	0.000303	CcSEcCtD
Guanabenz—Dermatitis—Cisplatin—lung cancer	0.000243	0.000302	CcSEcCtD
Guanabenz—Feeling abnormal—Docetaxel—lung cancer	0.000242	0.000301	CcSEcCtD
Guanabenz—Diarrhoea—Etoposide—lung cancer	0.000242	0.000301	CcSEcCtD
Guanabenz—Eye disorder—Doxorubicin—lung cancer	0.000241	0.0003	CcSEcCtD
Guanabenz—Ill-defined disorder—Methotrexate—lung cancer	0.000241	0.000299	CcSEcCtD
Guanabenz—Tinnitus—Doxorubicin—lung cancer	0.000241	0.000299	CcSEcCtD
Guanabenz—Gastrointestinal pain—Docetaxel—lung cancer	0.00024	0.000299	CcSEcCtD
Guanabenz—Anaemia—Methotrexate—lung cancer	0.00024	0.000298	CcSEcCtD
Guanabenz—Diarrhoea—Paclitaxel—lung cancer	0.000237	0.000295	CcSEcCtD
Guanabenz—Malaise—Methotrexate—lung cancer	0.000234	0.000291	CcSEcCtD
Guanabenz—Dizziness—Etoposide—lung cancer	0.000234	0.000291	CcSEcCtD
Guanabenz—Immune system disorder—Doxorubicin—lung cancer	0.000233	0.00029	CcSEcCtD
Guanabenz—Mediastinal disorder—Doxorubicin—lung cancer	0.000233	0.000289	CcSEcCtD
Guanabenz—Abdominal pain—Docetaxel—lung cancer	0.000232	0.000289	CcSEcCtD
Guanabenz—Body temperature increased—Docetaxel—lung cancer	0.000232	0.000289	CcSEcCtD
Guanabenz—Leukopenia—Methotrexate—lung cancer	0.000232	0.000289	CcSEcCtD
Guanabenz—Chills—Doxorubicin—lung cancer	0.000232	0.000288	CcSEcCtD
Guanabenz—Dizziness—Paclitaxel—lung cancer	0.000229	0.000285	CcSEcCtD
Guanabenz—Nausea—Cisplatin—lung cancer	0.000229	0.000285	CcSEcCtD
Guanabenz—Cough—Methotrexate—lung cancer	0.000226	0.000282	CcSEcCtD
Guanabenz—Vomiting—Etoposide—lung cancer	0.000225	0.00028	CcSEcCtD
Guanabenz—Erythema—Doxorubicin—lung cancer	0.000225	0.000279	CcSEcCtD
Guanabenz—Malnutrition—Doxorubicin—lung cancer	0.000225	0.000279	CcSEcCtD
Guanabenz—Rash—Etoposide—lung cancer	0.000223	0.000277	CcSEcCtD
Guanabenz—Dermatitis—Etoposide—lung cancer	0.000223	0.000277	CcSEcCtD
Guanabenz—Headache—Etoposide—lung cancer	0.000222	0.000275	CcSEcCtD
Guanabenz—Flatulence—Doxorubicin—lung cancer	0.000221	0.000275	CcSEcCtD
Guanabenz—Chest pain—Methotrexate—lung cancer	0.000221	0.000275	CcSEcCtD
Guanabenz—Arthralgia—Methotrexate—lung cancer	0.000221	0.000275	CcSEcCtD
Guanabenz—Myalgia—Methotrexate—lung cancer	0.000221	0.000275	CcSEcCtD
Guanabenz—Tension—Doxorubicin—lung cancer	0.000221	0.000274	CcSEcCtD
Guanabenz—Vomiting—Paclitaxel—lung cancer	0.00022	0.000274	CcSEcCtD
Guanabenz—Rash—Paclitaxel—lung cancer	0.000219	0.000272	CcSEcCtD
Guanabenz—Dermatitis—Paclitaxel—lung cancer	0.000218	0.000272	CcSEcCtD
Guanabenz—Discomfort—Methotrexate—lung cancer	0.000218	0.000271	CcSEcCtD
Guanabenz—Nervousness—Doxorubicin—lung cancer	0.000218	0.000271	CcSEcCtD
Guanabenz—Back pain—Doxorubicin—lung cancer	0.000217	0.00027	CcSEcCtD
Guanabenz—Headache—Paclitaxel—lung cancer	0.000217	0.00027	CcSEcCtD
Guanabenz—Hypersensitivity—Docetaxel—lung cancer	0.000217	0.000269	CcSEcCtD
Guanabenz—Muscle spasms—Doxorubicin—lung cancer	0.000216	0.000269	CcSEcCtD
Guanabenz—Confusional state—Methotrexate—lung cancer	0.000214	0.000266	CcSEcCtD
Guanabenz—Vision blurred—Doxorubicin—lung cancer	0.000212	0.000263	CcSEcCtD
Guanabenz—Asthenia—Docetaxel—lung cancer	0.000211	0.000262	CcSEcCtD
Guanabenz—Infection—Methotrexate—lung cancer	0.00021	0.000262	CcSEcCtD
Guanabenz—Nausea—Etoposide—lung cancer	0.00021	0.000261	CcSEcCtD
Guanabenz—Ill-defined disorder—Doxorubicin—lung cancer	0.000208	0.000259	CcSEcCtD
Guanabenz—Pruritus—Docetaxel—lung cancer	0.000208	0.000259	CcSEcCtD
Guanabenz—Nervous system disorder—Methotrexate—lung cancer	0.000208	0.000258	CcSEcCtD
Guanabenz—Anaemia—Doxorubicin—lung cancer	0.000208	0.000258	CcSEcCtD
Guanabenz—Thrombocytopenia—Methotrexate—lung cancer	0.000207	0.000258	CcSEcCtD
Guanabenz—Agitation—Doxorubicin—lung cancer	0.000207	0.000257	CcSEcCtD
Guanabenz—Nausea—Paclitaxel—lung cancer	0.000206	0.000256	CcSEcCtD
Guanabenz—Skin disorder—Methotrexate—lung cancer	0.000206	0.000256	CcSEcCtD
Guanabenz—Malaise—Doxorubicin—lung cancer	0.000203	0.000252	CcSEcCtD
Guanabenz—Anorexia—Methotrexate—lung cancer	0.000202	0.000251	CcSEcCtD
Guanabenz—Syncope—Doxorubicin—lung cancer	0.000202	0.000251	CcSEcCtD
Guanabenz—Leukopenia—Doxorubicin—lung cancer	0.000201	0.00025	CcSEcCtD
Guanabenz—Diarrhoea—Docetaxel—lung cancer	0.000201	0.00025	CcSEcCtD
Guanabenz—Hypotension—Methotrexate—lung cancer	0.000198	0.000246	CcSEcCtD
Guanabenz—Loss of consciousness—Doxorubicin—lung cancer	0.000198	0.000246	CcSEcCtD
Guanabenz—Cough—Doxorubicin—lung cancer	0.000196	0.000244	CcSEcCtD
Guanabenz—Dizziness—Docetaxel—lung cancer	0.000194	0.000242	CcSEcCtD
Guanabenz—Hypertension—Doxorubicin—lung cancer	0.000194	0.000241	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000193	0.00024	CcSEcCtD
Guanabenz—Chest pain—Doxorubicin—lung cancer	0.000191	0.000238	CcSEcCtD
Guanabenz—Arthralgia—Doxorubicin—lung cancer	0.000191	0.000238	CcSEcCtD
Guanabenz—Myalgia—Doxorubicin—lung cancer	0.000191	0.000238	CcSEcCtD
Guanabenz—Anxiety—Doxorubicin—lung cancer	0.000191	0.000237	CcSEcCtD
Guanabenz—Paraesthesia—Methotrexate—lung cancer	0.00019	0.000236	CcSEcCtD
Guanabenz—Discomfort—Doxorubicin—lung cancer	0.000189	0.000235	CcSEcCtD
Guanabenz—Dyspnoea—Methotrexate—lung cancer	0.000189	0.000235	CcSEcCtD
Guanabenz—Dry mouth—Doxorubicin—lung cancer	0.000187	0.000233	CcSEcCtD
Guanabenz—Vomiting—Docetaxel—lung cancer	0.000187	0.000232	CcSEcCtD
Guanabenz—Dyspepsia—Methotrexate—lung cancer	0.000186	0.000232	CcSEcCtD
Guanabenz—Rash—Docetaxel—lung cancer	0.000185	0.00023	CcSEcCtD
Guanabenz—Dermatitis—Docetaxel—lung cancer	0.000185	0.00023	CcSEcCtD
Guanabenz—Confusional state—Doxorubicin—lung cancer	0.000185	0.00023	CcSEcCtD
Guanabenz—Decreased appetite—Methotrexate—lung cancer	0.000184	0.000229	CcSEcCtD
Guanabenz—Headache—Docetaxel—lung cancer	0.000184	0.000229	CcSEcCtD
Guanabenz—Oedema—Doxorubicin—lung cancer	0.000183	0.000228	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Methotrexate—lung cancer	0.000183	0.000227	CcSEcCtD
Guanabenz—Fatigue—Methotrexate—lung cancer	0.000183	0.000227	CcSEcCtD
Guanabenz—Infection—Doxorubicin—lung cancer	0.000182	0.000227	CcSEcCtD
Guanabenz—Pain—Methotrexate—lung cancer	0.000181	0.000225	CcSEcCtD
Guanabenz—Shock—Doxorubicin—lung cancer	0.00018	0.000224	CcSEcCtD
Guanabenz—Nervous system disorder—Doxorubicin—lung cancer	0.00018	0.000224	CcSEcCtD
Guanabenz—Thrombocytopenia—Doxorubicin—lung cancer	0.00018	0.000223	CcSEcCtD
Guanabenz—Tachycardia—Doxorubicin—lung cancer	0.000179	0.000223	CcSEcCtD
Guanabenz—Skin disorder—Doxorubicin—lung cancer	0.000178	0.000222	CcSEcCtD
Guanabenz—Anorexia—Doxorubicin—lung cancer	0.000175	0.000217	CcSEcCtD
Guanabenz—Nausea—Docetaxel—lung cancer	0.000175	0.000217	CcSEcCtD
Guanabenz—Feeling abnormal—Methotrexate—lung cancer	0.000175	0.000217	CcSEcCtD
Guanabenz—Gastrointestinal pain—Methotrexate—lung cancer	0.000173	0.000215	CcSEcCtD
Guanabenz—Hypotension—Doxorubicin—lung cancer	0.000171	0.000213	CcSEcCtD
Guanabenz—Urticaria—Methotrexate—lung cancer	0.000168	0.000209	CcSEcCtD
Guanabenz—Abdominal pain—Methotrexate—lung cancer	0.000167	0.000208	CcSEcCtD
Guanabenz—Body temperature increased—Methotrexate—lung cancer	0.000167	0.000208	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000167	0.000208	CcSEcCtD
Guanabenz—Paraesthesia—Doxorubicin—lung cancer	0.000165	0.000205	CcSEcCtD
Guanabenz—Dyspnoea—Doxorubicin—lung cancer	0.000164	0.000203	CcSEcCtD
Guanabenz—Dyspepsia—Doxorubicin—lung cancer	0.000161	0.000201	CcSEcCtD
Guanabenz—Decreased appetite—Doxorubicin—lung cancer	0.000159	0.000198	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000158	0.000197	CcSEcCtD
Guanabenz—Fatigue—Doxorubicin—lung cancer	0.000158	0.000197	CcSEcCtD
Guanabenz—Pain—Doxorubicin—lung cancer	0.000157	0.000195	CcSEcCtD
Guanabenz—Constipation—Doxorubicin—lung cancer	0.000157	0.000195	CcSEcCtD
Guanabenz—Hypersensitivity—Methotrexate—lung cancer	0.000156	0.000194	CcSEcCtD
Guanabenz—Asthenia—Methotrexate—lung cancer	0.000152	0.000189	CcSEcCtD
Guanabenz—Feeling abnormal—Doxorubicin—lung cancer	0.000151	0.000188	CcSEcCtD
Guanabenz—Gastrointestinal pain—Doxorubicin—lung cancer	0.00015	0.000186	CcSEcCtD
Guanabenz—Pruritus—Methotrexate—lung cancer	0.00015	0.000186	CcSEcCtD
Guanabenz—Urticaria—Doxorubicin—lung cancer	0.000146	0.000181	CcSEcCtD
Guanabenz—Body temperature increased—Doxorubicin—lung cancer	0.000145	0.00018	CcSEcCtD
Guanabenz—Abdominal pain—Doxorubicin—lung cancer	0.000145	0.00018	CcSEcCtD
Guanabenz—Diarrhoea—Methotrexate—lung cancer	0.000145	0.00018	CcSEcCtD
Guanabenz—Dizziness—Methotrexate—lung cancer	0.00014	0.000174	CcSEcCtD
Guanabenz—Hypersensitivity—Doxorubicin—lung cancer	0.000135	0.000168	CcSEcCtD
Guanabenz—Vomiting—Methotrexate—lung cancer	0.000135	0.000167	CcSEcCtD
Guanabenz—Rash—Methotrexate—lung cancer	0.000134	0.000166	CcSEcCtD
Guanabenz—Dermatitis—Methotrexate—lung cancer	0.000133	0.000166	CcSEcCtD
Guanabenz—Headache—Methotrexate—lung cancer	0.000133	0.000165	CcSEcCtD
Guanabenz—Asthenia—Doxorubicin—lung cancer	0.000132	0.000164	CcSEcCtD
Guanabenz—Pruritus—Doxorubicin—lung cancer	0.00013	0.000161	CcSEcCtD
Guanabenz—Nausea—Methotrexate—lung cancer	0.000126	0.000156	CcSEcCtD
Guanabenz—Diarrhoea—Doxorubicin—lung cancer	0.000125	0.000156	CcSEcCtD
Guanabenz—Dizziness—Doxorubicin—lung cancer	0.000121	0.000151	CcSEcCtD
Guanabenz—Vomiting—Doxorubicin—lung cancer	0.000117	0.000145	CcSEcCtD
Guanabenz—Rash—Doxorubicin—lung cancer	0.000116	0.000144	CcSEcCtD
Guanabenz—Dermatitis—Doxorubicin—lung cancer	0.000116	0.000144	CcSEcCtD
Guanabenz—Headache—Doxorubicin—lung cancer	0.000115	0.000143	CcSEcCtD
Guanabenz—Nausea—Doxorubicin—lung cancer	0.000109	0.000135	CcSEcCtD
Guanabenz—ADRA2B—Signaling by GPCR—IL2—lung cancer	3.41e-05	0.00022	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—HRAS—lung cancer	3.41e-05	0.00022	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TERT—lung cancer	3.4e-05	0.00022	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALDOA—lung cancer	3.37e-05	0.000218	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CXCL8—lung cancer	3.33e-05	0.000215	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FOXO3—lung cancer	3.32e-05	0.000215	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CYP1A1—lung cancer	3.32e-05	0.000214	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ERBB3—lung cancer	3.31e-05	0.000214	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—FGFR1—lung cancer	3.3e-05	0.000213	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ERCC2—lung cancer	3.29e-05	0.000213	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NCOA3—lung cancer	3.28e-05	0.000212	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—KRAS—lung cancer	3.26e-05	0.000211	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—MAP2K1—lung cancer	3.25e-05	0.00021	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HIF1A—lung cancer	3.25e-05	0.00021	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CD—lung cancer	3.23e-05	0.000209	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—AKT1—lung cancer	3.22e-05	0.000208	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.22e-05	0.000208	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CG—lung cancer	3.2e-05	0.000207	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ADCY1—lung cancer	3.19e-05	0.000206	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ABCG2—lung cancer	3.19e-05	0.000206	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL2—lung cancer	3.18e-05	0.000206	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TERT—lung cancer	3.17e-05	0.000205	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOA1—lung cancer	3.13e-05	0.000203	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HPGDS—lung cancer	3.12e-05	0.000202	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ENO2—lung cancer	3.12e-05	0.000202	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AVP—lung cancer	3.11e-05	0.000201	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KDR—lung cancer	3.11e-05	0.000201	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPP2R1B—lung cancer	3.1e-05	0.000201	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CB—lung cancer	3.1e-05	0.000201	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FGFR1—lung cancer	3.08e-05	0.000199	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.06e-05	0.000198	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—POMC—lung cancer	3.04e-05	0.000197	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HIF1A—lung cancer	3.03e-05	0.000196	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GSTT1—lung cancer	3.03e-05	0.000196	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—AKT1—lung cancer	3.01e-05	0.000195	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GCLC—lung cancer	3e-05	0.000194	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP2A6—lung cancer	3e-05	0.000194	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF1R—lung cancer	2.99e-05	0.000194	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—PIK3CA—lung cancer	2.99e-05	0.000193	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.98e-05	0.000193	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CXCL8—lung cancer	2.98e-05	0.000193	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CREBBP—lung cancer	2.96e-05	0.000192	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HES1—lung cancer	2.94e-05	0.00019	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOA1—lung cancer	2.93e-05	0.000189	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KDR—lung cancer	2.9e-05	0.000188	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TP53—lung cancer	2.89e-05	0.000187	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—RAF1—lung cancer	2.88e-05	0.000187	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KIT—lung cancer	2.86e-05	0.000185	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APC—lung cancer	2.86e-05	0.000185	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CG—lung cancer	2.86e-05	0.000185	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—NRAS—lung cancer	2.86e-05	0.000185	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—IL2—lung cancer	2.85e-05	0.000184	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOA1—lung cancer	2.84e-05	0.000184	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ENO1—lung cancer	2.84e-05	0.000184	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.83e-05	0.000183	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EGF—lung cancer	2.83e-05	0.000183	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CB—lung cancer	2.82e-05	0.000182	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CD—lung cancer	2.81e-05	0.000182	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.79e-05	0.000181	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ALB—lung cancer	2.77e-05	0.000179	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—HRAS—lung cancer	2.77e-05	0.000179	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—MAPK3—lung cancer	2.74e-05	0.000177	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—POMC—lung cancer	2.72e-05	0.000176	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CXCL8—lung cancer	2.71e-05	0.000175	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—BRAF—lung cancer	2.69e-05	0.000174	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ERBB3—lung cancer	2.69e-05	0.000174	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APC—lung cancer	2.67e-05	0.000173	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KIT—lung cancer	2.67e-05	0.000173	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CG—lung cancer	2.67e-05	0.000173	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—NRAS—lung cancer	2.67e-05	0.000173	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6R—lung cancer	2.66e-05	0.000172	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CREBBP—lung cancer	2.65e-05	0.000172	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EGF—lung cancer	2.64e-05	0.000171	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—EGFR—lung cancer	2.61e-05	0.000169	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CG—lung cancer	2.6e-05	0.000168	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL2—lung cancer	2.59e-05	0.000167	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TERT—lung cancer	2.58e-05	0.000167	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—MAPK3—lung cancer	2.56e-05	0.000166	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP2E1—lung cancer	2.55e-05	0.000165	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—POMC—lung cancer	2.54e-05	0.000165	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MAP2K1—lung cancer	2.53e-05	0.000164	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NQO1—lung cancer	2.52e-05	0.000163	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CD—lung cancer	2.52e-05	0.000163	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—BRAF—lung cancer	2.51e-05	0.000162	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FGFR1—lung cancer	2.5e-05	0.000162	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—PIK3CA—lung cancer	2.49e-05	0.000161	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6R—lung cancer	2.48e-05	0.000161	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CREBBP—lung cancer	2.48e-05	0.00016	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—POMC—lung cancer	2.47e-05	0.00016	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.47e-05	0.000159	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HIF1A—lung cancer	2.46e-05	0.000159	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—KRAS—lung cancer	2.46e-05	0.000159	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CB—lung cancer	2.45e-05	0.000158	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—AKT1—lung cancer	2.44e-05	0.000158	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.44e-05	0.000158	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—EGFR—lung cancer	2.44e-05	0.000157	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTGS2—lung cancer	2.43e-05	0.000157	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CREBBP—lung cancer	2.41e-05	0.000156	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOA1—lung cancer	2.38e-05	0.000154	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MAP2K1—lung cancer	2.37e-05	0.000153	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KDR—lung cancer	2.36e-05	0.000152	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CD—lung cancer	2.35e-05	0.000152	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—PIK3CA—lung cancer	2.33e-05	0.000151	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—KRAS—lung cancer	2.3e-05	0.000149	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CD—lung cancer	2.28e-05	0.000148	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—STK11—lung cancer	2.27e-05	0.000147	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PIK3CA—lung cancer	2.26e-05	0.000146	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MDM2—lung cancer	2.25e-05	0.000146	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ALB—lung cancer	2.25e-05	0.000146	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RAF1—lung cancer	2.25e-05	0.000145	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ERBB2—lung cancer	2.22e-05	0.000144	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MTOR—lung cancer	2.19e-05	0.000142	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CB—lung cancer	2.19e-05	0.000142	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KIT—lung cancer	2.17e-05	0.00014	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APC—lung cancer	2.17e-05	0.00014	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CG—lung cancer	2.17e-05	0.00014	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—NRAS—lung cancer	2.17e-05	0.00014	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EGF—lung cancer	2.15e-05	0.000139	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.13e-05	0.000138	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTEN—lung cancer	2.12e-05	0.000137	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3CA—lung cancer	2.11e-05	0.000137	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CXCL8—lung cancer	2.11e-05	0.000136	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MDM2—lung cancer	2.11e-05	0.000136	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GSTP1—lung cancer	2.1e-05	0.000136	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RAF1—lung cancer	2.1e-05	0.000136	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—HRAS—lung cancer	2.09e-05	0.000135	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—MAPK3—lung cancer	2.08e-05	0.000134	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ERBB2—lung cancer	2.08e-05	0.000134	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—POMC—lung cancer	2.07e-05	0.000134	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CB—lung cancer	2.05e-05	0.000132	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MTOR—lung cancer	2.05e-05	0.000132	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CAT—lung cancer	2.04e-05	0.000132	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—BRAF—lung cancer	2.04e-05	0.000132	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AKT1—lung cancer	2.04e-05	0.000132	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.03e-05	0.000131	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—EP300—lung cancer	2.02e-05	0.000131	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CASP3—lung cancer	2.02e-05	0.00013	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6R—lung cancer	2.02e-05	0.00013	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL2—lung cancer	2.01e-05	0.00013	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CREBBP—lung cancer	2.01e-05	0.00013	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL6—lung cancer	2e-05	0.00013	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CB—lung cancer	1.99e-05	0.000129	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ABCB1—lung cancer	1.99e-05	0.000129	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—EGFR—lung cancer	1.98e-05	0.000128	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTGS2—lung cancer	1.97e-05	0.000127	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CXCL8—lung cancer	1.97e-05	0.000127	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCND1—lung cancer	1.96e-05	0.000127	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—JUN—lung cancer	1.96e-05	0.000127	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—HRAS—lung cancer	1.96e-05	0.000126	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—TYMS—lung cancer	1.95e-05	0.000126	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GSTM1—lung cancer	1.93e-05	0.000125	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	1.92e-05	0.000124	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	1.91e-05	0.000123	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MMP9—lung cancer	1.91e-05	0.000123	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AKT1—lung cancer	1.9e-05	0.000123	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CDKN1A—lung cancer	1.9e-05	0.000123	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PTEN—lung cancer	1.89e-05	0.000123	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	1.89e-05	0.000122	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CASP3—lung cancer	1.88e-05	0.000122	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL2—lung cancer	1.88e-05	0.000122	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL6—lung cancer	1.87e-05	0.000121	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—KRAS—lung cancer	1.87e-05	0.000121	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AKT1—lung cancer	1.85e-05	0.00012	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCND1—lung cancer	1.83e-05	0.000119	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP1A1—lung cancer	1.83e-05	0.000118	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—JUN—lung cancer	1.83e-05	0.000118	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ERCC2—lung cancer	1.81e-05	0.000117	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EP300—lung cancer	1.81e-05	0.000117	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MMP9—lung cancer	1.78e-05	0.000115	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CDKN1A—lung cancer	1.77e-05	0.000115	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PTEN—lung cancer	1.77e-05	0.000114	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SRC—lung cancer	1.76e-05	0.000114	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AKT1—lung cancer	1.73e-05	0.000112	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTEN—lung cancer	1.72e-05	0.000111	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	1.72e-05	0.000111	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—VEGFA—lung cancer	1.71e-05	0.000111	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MDM2—lung cancer	1.71e-05	0.000111	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RAF1—lung cancer	1.7e-05	0.00011	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—STAT3—lung cancer	1.69e-05	0.00011	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NRAS—lung cancer	1.69e-05	0.000109	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EP300—lung cancer	1.69e-05	0.000109	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ERBB2—lung cancer	1.69e-05	0.000109	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MTOR—lung cancer	1.66e-05	0.000108	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	1.66e-05	0.000108	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SRC—lung cancer	1.64e-05	0.000106	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—EP300—lung cancer	1.64e-05	0.000106	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MAPK3—lung cancer	1.62e-05	0.000105	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CXCL8—lung cancer	1.6e-05	0.000103	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—VEGFA—lung cancer	1.6e-05	0.000103	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—HRAS—lung cancer	1.59e-05	0.000103	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—STAT3—lung cancer	1.58e-05	0.000102	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NRAS—lung cancer	1.58e-05	0.000102	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MYC—lung cancer	1.57e-05	0.000102	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOA1—lung cancer	1.57e-05	0.000102	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	1.54e-05	9.99e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EGFR—lung cancer	1.54e-05	9.96e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CASP3—lung cancer	1.53e-05	9.9e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL2—lung cancer	1.53e-05	9.88e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL6—lung cancer	1.52e-05	9.83e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MAPK3—lung cancer	1.51e-05	9.78e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.5e-05	9.72e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CA—lung cancer	1.49e-05	9.66e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCND1—lung cancer	1.49e-05	9.63e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—JUN—lung cancer	1.49e-05	9.61e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MYC—lung cancer	1.47e-05	9.51e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KRAS—lung cancer	1.45e-05	9.41e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MMP9—lung cancer	1.45e-05	9.35e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	1.44e-05	9.32e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EGFR—lung cancer	1.44e-05	9.3e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTEN—lung cancer	1.44e-05	9.3e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CG—lung cancer	1.43e-05	9.27e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT1—lung cancer	1.4e-05	9.07e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EP300—lung cancer	1.37e-05	8.87e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—POMC—lung cancer	1.36e-05	8.82e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KRAS—lung cancer	1.36e-05	8.79e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	1.34e-05	8.64e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SRC—lung cancer	1.33e-05	8.62e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CREBBP—lung cancer	1.33e-05	8.59e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—VEGFA—lung cancer	1.3e-05	8.4e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TP53—lung cancer	1.29e-05	8.36e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—STAT3—lung cancer	1.29e-05	8.31e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NRAS—lung cancer	1.28e-05	8.29e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CD—lung cancer	1.26e-05	8.15e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CA—lung cancer	1.25e-05	8.07e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALB—lung cancer	1.24e-05	8.04e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HRAS—lung cancer	1.24e-05	8e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MAPK3—lung cancer	1.23e-05	7.94e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AKT1—lung cancer	1.22e-05	7.89e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CA—lung cancer	1.21e-05	7.84e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TP53—lung cancer	1.21e-05	7.81e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MYC—lung cancer	1.19e-05	7.73e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6—lung cancer	1.18e-05	7.65e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EGFR—lung cancer	1.17e-05	7.56e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HRAS—lung cancer	1.16e-05	7.47e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6—lung cancer	1.11e-05	7.15e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KRAS—lung cancer	1.1e-05	7.14e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CB—lung cancer	1.1e-05	7.1e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT1—lung cancer	1.09e-05	7.06e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTGS2—lung cancer	1.09e-05	7.04e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT1—lung cancer	1.02e-05	6.6e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	1.01e-05	6.56e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AKT1—lung cancer	9.91e-06	6.41e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TP53—lung cancer	9.81e-06	6.34e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTEN—lung cancer	9.49e-06	6.14e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HRAS—lung cancer	9.38e-06	6.07e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—EP300—lung cancer	9.05e-06	5.85e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6—lung cancer	8.98e-06	5.81e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT1—lung cancer	8.28e-06	5.36e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CA—lung cancer	6.7e-06	4.33e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKT1—lung cancer	5.47e-06	3.54e-05	CbGpPWpGaD
